The United States Prostate Cancer Biomarkers Market is projected to grow from $1.48 billion in 2024 to $3.54 billion by 2033, ...

Adelaide researchers have identified a promising new biomarker and treatment target for ovarian cancer that could markedly ...

The researchers argue that the integration of explainable AI into clinical decision-making pipelines could reshape cancer ...

Guardant Health (Nasdaq: GH), a leading precision oncology company, and Zephyr AI, a leader in precision medicine harnessing artificial intelligence to accelerate drug development, today announced a ...

An AI system has been designed to aid cancer diagnosis, providing insights into subtyping, biomarker quantification, ...

Circulating tumor DNA (ctDNA) is a promising biomarker for monitoring treatment response and progression-free survival in ...

Biomarkers identified in BriaCell’s Phase 2 study are showing similar and encouraging trends in the ongoing pivotal Phase 3 ...

Biomarkers are pivotal for confirming diagnoses, predicting disease progression, and tailoring therapeutic modalities. Recent ...

A recent publication in JACC: Advances shows a previously unrecognized link between cardiac disease and cancer. The research focused on cardiac biomarkers, which are biological molecules that can ...

Early detection and prevention of cancer can save lives, but current tools often fall short because of suboptimal accuracy and limited accessibility. The Fred Hutch Cancer Center aims to change that ...

When Ginny Mason was diagnosed with inflammatory breast cancer in 1994, she never once heard the word “biomarker.” “Back then, all you got was ER and PR [the estrogen receptor and progesterone ...

Please provide your email address to receive an email when new articles are posted on . Elevated levels of cardiac biomarkers were indicative of future cancer risk. The association between biomarkers ...